about
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.Polylactide-cyclosporin A nanoparticles for targeted immunosuppression.The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.Divergent role of donor dendritic cells in rejection versus tolerance of allografts.The role of HCA2 (GPR109A) in regulating macrophage function.Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing.Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection.Role of CXC chemokine receptor 3 pathway in renal ischemic injury.Role of beta3 integrin in acute renal allograft rejection in humans.Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation.Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo?3 Integrins Regulate Lymphocyte Migration and Cytokine Responses in Heart Transplant RejectionDifferential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivoCharacterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survivalPhenotypic and functional differences between wild-type and CCR2-/- dendritic cells: implications for islet transplantationA link between PDL1 and T regulatory cells in fetomaternal toleranceImportance of donor- and recipient-derived selectins in cardiac allograft rejectionIschemic injury enhances dendritic cell immunogenicity via TLR4 and NF-kappa B activationHLA-DO Modulates the Diversity of the MHC-II Self-peptidomeClass II MHC antigen processing in immune tolerance and inflammation
P50
Q34082857-1161939A-5AB2-49BF-B24A-3AD0C4982031Q34355278-9D8924E4-AAA3-486F-BCAA-02B3D88E6AABQ34378940-11DBA04D-549C-4983-8C97-83DA78B72EF3Q35976619-8FF93AA1-8FBC-4DFA-ACE9-4E0827F96ABAQ36943737-F1E1AD1C-33EF-469C-9012-0813E283BA61Q37123243-FAAB040E-8DDF-4BA2-BD26-A66951706FEEQ37245946-9A3B7B0B-3A9A-4B4B-B1BA-3945696E1F95Q37492370-6F313E0E-0F29-44ED-B88C-74F391DDD7F2Q41964589-DB12A0DA-70B3-4FC9-9FF1-EC0BB2CA0F16Q44203854-723A5908-C8CC-427F-8D92-CF413F62D505Q46859562-BA9737A4-C9D7-4B92-B37F-DED486D9B291Q46947108-EC81D0BB-AFD6-422F-9375-35729596D37EQ46956749-B45CF435-D94D-4900-9010-F691ED26EB87Q53568433-BBD1DCC2-FB5F-4E50-ADCB-4763002506EBQ56902821-75A1A0EC-2367-40B6-B261-75F554F37560Q63383601-8F36DDAD-17E5-4B41-8E32-69FB6A2AFD60Q75224515-C7F5E5CC-B2BE-4237-BAC5-E8F4DF5B2A34Q79743556-35C30F0C-7D77-41CE-BEF3-DD7757C3150DQ81072238-2A8DD718-0EC8-4EEA-844F-5FF7BD6F7F3DQ81386275-BDD1BF2E-C878-4A6A-AECF-3D8708C95342Q81421319-55E15C3A-F873-430B-8665-D0A64192A990Q82940816-409BC599-8CE7-4809-B39C-5F694CE157C0Q90681131-9514700A-78FD-42C9-8EB1-5F756AB28A4FQ93020630-F03352EC-4A17-440C-B8D0-D1F4A3973FB9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mollie Jurewicz
@ast
Mollie Jurewicz
@en
Mollie Jurewicz
@es
Mollie Jurewicz
@nl
Mollie Jurewicz
@sl
type
label
Mollie Jurewicz
@ast
Mollie Jurewicz
@en
Mollie Jurewicz
@es
Mollie Jurewicz
@nl
Mollie Jurewicz
@sl
prefLabel
Mollie Jurewicz
@ast
Mollie Jurewicz
@en
Mollie Jurewicz
@es
Mollie Jurewicz
@nl
Mollie Jurewicz
@sl
P106
P31
P496
0000-0001-8482-3060